Kezar Life Sciences, Inc. (KZR) Change in Acquisitions & Divestments (2019 - 2025)

Kezar Life Sciences has reported Change in Acquisitions & Divestments for 7 years, with the latest figure at $51.5 million in Q4 2025.

• Quarterly Change in Acquisitions & Divestments rose 19.8% year-over-year to $51.5 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $121.2 million (down 17.97% YoY) and the FY2025 annual result came in at $135.0 million, down 21.43% from the prior year.
• Change in Acquisitions & Divestments grew to $51.5 million in Q4 2025 per KZR's latest filing, from $30.0 million in the prior quarter.
• Over five years, Change in Acquisitions & Divestments peaked at $85.2 million in Q4 2022 and troughed at $13.8 million in Q1 2025.
• A 5-year average of $46.8 million and a median of $43.9 million in 2021 frame the typical range for Change in Acquisitions & Divestments.
• The sharpest annual moves came in 2023 and 2025: Change in Acquisitions & Divestments surged 358.26% in 2023, then tumbled 63.58% in 2025.
• Over 5 years, Change in Acquisitions & Divestments stood at $31.0 million in 2021, then soared by 175.0% to $85.2 million in 2022, then declined by 8.8% to $77.8 million in 2023, then plunged by 44.71% to $43.0 million in 2024, then advanced by 19.8% to $51.5 million in 2025.
• According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $51.5 million, $30.0 million, and $39.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.